This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Novo-Gesic
- Starting date:
- March 14, 2013
- Posting date:
- April 2, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-26483
Recalled Products
- Novo-Gesic
Reason
Teva Canada initiated the voluntary recall due to potential microbial contamination of the product.
Depth of distribution
Recall to retail level: Distribution in Canada
Affected products
A. Novo-Gesic
DIN, NPN, DIN-HIM
DIN 00389218
Dosage form
- Tablet
Strength
- 325 mg
Lot or serial number
- 35329880G
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA